NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Net Sales | ₹301 Cr | ₹278 Cr | ₹13,770,298 Cr | ₹124 Cr | ₹124 Cr |
What is the latest Revenue of NATH BIOGENES (INDIA) ?
Year | Revenue |
---|---|
Mar2024 | ₹301 Cr |
Mar2023 | ₹278 Cr |
Mar2022 | ₹13,770,298 Cr |
Mar2013 | ₹124 Cr |
Mar2012 | ₹124 Cr |
How is Revenue of NATH BIOGENES (INDIA) Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹301 Cr | 8.26 | |
Mar2023 | ₹278 Cr | -100.00 | |
Mar2022 | ₹13,770,298 Cr | 11,112,596.80 | |
Mar2013 | ₹124 Cr | 0.00 | |
Mar2012 | ₹124 Cr | - |
Compare Revenue of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹377.2 Cr | -2.4% | 5.6% | -1% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,934.7 Cr | -5.8% | -6.3% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,436.8 Cr | -5.7% | -15.3% | 32.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,264.3 Cr | -1.5% | 0.4% | -16.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,435.5 Cr | -2% | -1.8% | -33.7% | Stock Analytics | |
INDO US BIOTECH | ₹307.9 Cr | 1.5% | 1.6% | -27% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -2.4% |
5.6% |
-1% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses